Pharmagest Net Working Capital from 2010 to 2026

PHF Stock  EUR 33.95  18.82  35.66%   
Pharmagest Interactive's Net Working Capital is decreasing over the last several years with slightly volatile swings. Net Working Capital is estimated to finish at about 27.6 M this year. During the period from 2010 to 2026 Pharmagest Interactive SA Net Working Capital regressed destribution of quarterly values had coefficient of variationof  33.18 and r-value of (0.88). View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
21.7 M
Current Value
27.6 M
Quarterly Volatility
13.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Pharmagest Interactive financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmagest Interactive's main balance sheet or income statement drivers, such as Tax Provision of 8.8 M, Net Interest Income of 2.7 M or Discontinued Operations of 108.6 K, as well as many indicators such as . Pharmagest financial statements analysis is a perfect complement when working with Pharmagest Interactive Valuation or Volatility modules.
  
This module can also supplement various Pharmagest Interactive Technical models . Check out the analysis of Pharmagest Interactive Correlation against competitors.
The Net Working Capital trend for Pharmagest Interactive SA offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pharmagest Interactive is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Pharmagest Interactive's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Pharmagest Interactive SA over the last few years. It is Pharmagest Interactive's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharmagest Interactive's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Pharmagest Net Working Capital Regression Statistics

Arithmetic Mean40,534,582
Geometric Mean38,248,155
Coefficient Of Variation33.18
Mean Deviation12,300,325
Median42,068,000
Standard Deviation13,448,083
Sample Variance180.9T
Range31.7M
R-Value(0.88)
Mean Square Error42.5T
R-Squared0.78
Slope(2,351,535)
Total Sum of Squares2893.6T

Pharmagest Net Working Capital History

202627.6 M
202521.7 M
202324.1 M
202239 M
202128.2 M
202029.5 M
201925.4 M

About Pharmagest Interactive Financial Statements

Pharmagest Interactive stakeholders use historical fundamental indicators, such as Pharmagest Interactive's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Pharmagest Interactive investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharmagest Interactive's assets and liabilities are reflected in the revenues and expenses on Pharmagest Interactive's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharmagest Interactive SA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital21.7 M27.6 M

Currently Active Assets on Macroaxis

Other Information on Investing in Pharmagest Stock

Pharmagest Interactive financial ratios help investors to determine whether Pharmagest Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagest with respect to the benefits of owning Pharmagest Interactive security.